Future screening of additional androgen receptor-positive PCa cell lines (e.g. LNCaP, VCaP, DUCaP, 22Rv1)56 that have been treated with bicalutamide, as well as assaying androgen receptor-negative cell lines from other cancer types, will help clarify this point. The gene discussed is AR; the disease is posterior cortical atrophy.